What is ALVOW stock price today?

ALVOW (Alvotech) stock is trading at $0.37 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ALVOW stock going up or down today?

ALVOW stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ALVOW stock now?

The decision to buy ALVOW depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ALVOW a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ALVOW based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ALVOW stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ALVOW is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ALVOW's P/E ratio?

P/E ratio data for ALVOW will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ALVOW's market cap?

Visit our dashboard for ALVOW's current market capitalization and other key metrics.

What is ALVOW's price to book ratio?

Price-to-book ratio for ALVOW is available on our dashboard along with other valuation metrics.

Does ALVOW pay dividends?

ALVOW does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ALVOW's dividend yield?

ALVOW does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ALVOW stock a good long-term investment?

ALVOW's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ALVOW's revenue growth rate?

ALVOW has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, ALVOW is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in ALVOW?

Key risks for ALVOW include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ALVOW compare to its competitors?

Compare ALVOW to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ALVOW's performance and positioning.

What is ALVOW's stock price target for 2026?

Our AI model provides price targets for ALVOW based on fundamental analysis: Bull case $0.47 (+30%), Base case $0.42 (+15%), Bear case $0.33 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ALVOW?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ALVOW. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ALVOW's next earnings report?

ALVOW reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ALVOW - Alvotech

NYSE

$0.37

+$0.02 (+4.37%)

About Alvotech

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

ALVOW Key Statistics

Market Cap

$0.00M

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

1,012

How ALVOW Compares to Peers

ALVOW has the highest profit margins in its peer group

P/E Rank

N/A

of 1

Margin Rank

of 2

Growth Rank

of 2

Size Rank

N/A

of 1

Company	Market Cap	P/E	Growth	Margin	Compare
ALVOW(This stock)	$0.00	N/A	0%	0.1%	-
AMZNAmazon Com	$2.30T	29.9	0%	0.1%	vs AMZN

Alvotech Company Information

Headquarters: 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273, undefined
Website: www.alvotech.com

About Alvotech

ALVOW Key Statistics

How ALVOW Compares to Peers

Alvotech Company Information

Upcoming Events for ALVOW